Obesity and Cancer

The article examines the importance of managing weight to reduce risk for developing cancer and for survival among cancer patients and presents a set of strategies that can be useful to guide clinical advice to patients for whom weight control is an important adjunct to risk management or to improve quality of life and disease-free survival after diagnosis.

[1]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[2]  Yoke Yeen.  Title , 2011, Respiratory Physiology & Neurobiology.

[3]  D. Sargent,et al.  Obesity Is an Independent Prognostic Variable in Colon Cancer Survivors , 2010, Clinical Cancer Research.

[4]  A. Kibel,et al.  Risk of urinary incontinence following prostatectomy: the role of physical activity and obesity. , 2010, The Journal of urology.

[5]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.

[6]  C. Dive,et al.  Biological mechanisms linking obesity and cancer risk: new perspectives. , 2010, Annual review of medicine.

[7]  J. Moul,et al.  The Shared Equal Access Regional Cancer Hospital (SEARCH) nomogram for risk stratification in intermediate risk group of men with prostate cancer: validation in the Duke Prostate Center database , 2010, BJU international.

[8]  Susan T. Stewart,et al.  Forecasting the effects of obesity and smoking on U.S. life expectancy. , 2009, The New England journal of medicine.

[9]  G. Landman,et al.  Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes , 2009, Diabetes Care.

[10]  D. Albanes,et al.  Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. , 2009, Journal of the National Cancer Institute.

[11]  J. Wong,et al.  Potential for higher treatment failure in obese patients: correlation of elevated body mass index and increased daily prostate deviations from the radiation beam isocenters in an analysis of 1,465 computed tomographic images. , 2009, International journal of radiation oncology, biology, physics.

[12]  E. Giovannucci,et al.  A Cohort Study of STMN1 Expression in Colorectal Cancer: Body Mass Index and Prognosis , 2009, The American Journal of Gastroenterology.

[13]  C. Ulrich,et al.  Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  B. Martín-Castillo,et al.  mTOR inhibitors and the anti-diabetic biguanide metformin: new insights into the molecular management of breast cancer resistance to the HER2 tyrosine kinase inhibitor lapatinib (Tykerb®) , 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[15]  P. Goodwin,et al.  Metformin in breast cancer: time for action. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  C. Bouchard,et al.  Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. , 2009, The Lancet. Oncology.

[17]  K. Courneya,et al.  Effects of Exercise on Quality of Life and Prognosis in Cancer Survivors , 2009, Current sports medicine reports.

[18]  P. Donnan,et al.  New Users of Metformin Are at Low Risk of Incident Cancer , 2009, Diabetes Care.

[19]  S. Modesitt,et al.  Cancer in obese women: potential protective impact of bariatric surgery. , 2009, Journal of the American College of Surgeons.

[20]  A. Thor,et al.  Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro , 2009, Cell cycle.

[21]  J. Menéndez,et al.  The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells , 2009, Cell cycle.

[22]  N. Christou,et al.  Bariatric surgery reduces cancer risk in morbidly obese patients. , 2008, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[23]  J. Meyerhardt,et al.  Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  S. Perkins,et al.  Reducing the weight of cancer: mechanistic targets for breaking the obesity-carcinogenesis link. , 2008, Best practice & research. Clinical endocrinology & metabolism.

[25]  M. Schwenkglenks,et al.  Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy , 2008, Annals of Hematology.

[26]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[27]  E. Small,et al.  Inverse correlation between body mass index and clinical outcomes in men with advanced castration–recurrent prostate cancer , 2007, Cancer.

[28]  P. Parfrey,et al.  Excess Body Weight and Colorectal Cancer Risk in Canada: Associations in Subgroups of Clinically Defined Familial Risk of Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[29]  S. Stroup,et al.  Effect of obesity on prostate‐specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group‐American Society for Therapeutic Radiation and Oncology (RTOG‐ASTRO) Phoenix consensus definition , 2007, Cancer.

[30]  E. Giovannucci.  Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. , 2007, The American journal of clinical nutrition.

[31]  Claude Bouchard,et al.  Effects of bariatric surgery on mortality in Swedish obese subjects. , 2007, The New England journal of medicine.

[32]  Steven C Hunt,et al.  Long-term mortality after gastric bypass surgery. , 2007, The New England journal of medicine.

[33]  J. Verweij,et al.  Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference? , 2007, The oncologist.

[34]  Robert M Elashoff,et al.  Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.

[35]  N. Wolmark,et al.  Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. , 2006, Journal of the National Cancer Institute.

[36]  H. Halperin,et al.  Long‐Term Safety and Efficacy of Circumferential Ablation with Pulmonary Vein Isolation , 2006, Journal of cardiovascular electrophysiology.

[37]  K. Emmons,et al.  Television viewing and pedometer-determined physical activity among multiethnic residents of low-income housing. , 2006, American journal of public health.

[38]  W. Willett,et al.  Adult weight change and risk of postmenopausal breast cancer. , 2006, JAMA.

[39]  C. Camargo,et al.  Body-mass index and symptoms of gastroesophageal reflux in women. , 2006, The New England journal of medicine.

[40]  K. Emmons,et al.  Pedometer-determined physical activity among multiethnic low-income housing residents. , 2006, Medicine and science in sports and exercise.

[41]  M. Terris,et al.  Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  J. Griggs,et al.  Undertreatment of obese women receiving breast cancer chemotherapy. , 2005, Archives of internal medicine.

[43]  S. Hankinson,et al.  A Prospective Study of C-Peptide, Insulin-like Growth Factor-I, Insulin-like Growth Factor Binding Protein-1, and the Risk of Colorectal Cancer in Women , 2005, Cancer Epidemiology Biomarkers & Prevention.

[44]  B. Rosner,et al.  Weight, weight gain, and survival after breast cancer diagnosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  S. Hankinson,et al.  Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. , 2004, Journal of the National Cancer Institute.

[46]  S. Cummings,et al.  Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. , 2004, Journal of the National Cancer Institute.

[47]  Sheana S Bull,et al.  Interactive behavior change technology. A partial solution to the competing demands of primary care. , 2004, American journal of preventive medicine.

[48]  Graham A Colditz,et al.  Physical activity and survival after breast cancer diagnosis. , 2004, JAMA.

[49]  S. Cummings,et al.  Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. , 2003, Journal of the National Cancer Institute.

[50]  J. Meyerhardt,et al.  Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma , 2003, Cancer.

[51]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[52]  Walter C Willett,et al.  Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. , 2003, JAMA.

[53]  G. Colditz,et al.  One-year changes in activity and in inactivity among 10- to 15-year-old boys and girls: relationship to change in body mass index. , 2003, Pediatrics.

[54]  K. Flegal,et al.  Prevalence and trends in obesity among US adults, 1999-2000. , 2002, JAMA.

[55]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[56]  E. Winer,et al.  Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  J. Manson,et al.  A prospective study of weight change and health-related quality of life in women. , 1999, JAMA.

[58]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[59]  N. Anderssen.  Physical Activity and Behavioral Medicine , 1999, Journal of health psychology.

[60]  C. la Vecchia,et al.  Body size and colorectal‐cancer risk , 1998, International journal of cancer.

[61]  J. Manson,et al.  Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States) , 1995, Cancer Causes & Control.

[62]  E. Giovannucci.  Insulin and colon cancer , 1995, Cancer Causes & Control.

[63]  R. Coates,et al.  Race, nutritional status, and survival from breast cancer. , 1990, Journal of the National Cancer Institute.

[64]  N. Boyd,et al.  Body size and breast cancer prognosis: A critical review of the evidence , 1990, Breast Cancer Research and Treatment.

[65]  D. D. Bois,et al.  CLINICAL CALORIMETRY: TENTH PAPER A FORMULA TO ESTIMATE THE APPROXIMATE SURFACE AREA IF HEIGHT AND WEIGHT BE KNOWN , 1916 .

[66]  F. Ovalle.  Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16 , 2010 .

[67]  J. Klenk,et al.  Weight change and cancer risk in a cohort of more than 65,000 adults in Austria. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[68]  F. Frasca,et al.  The role of insulin receptors and IGF-I receptors in cancer and other diseases. , 2008, Archives of physiology and biochemistry.

[69]  Peter D Siersema,et al.  Esophageal cancer. , 2008, Gastroenterology clinics of North America.

[70]  E. Platz,et al.  Obesity and prostate cancer: making sense out of apparently conflicting data. , 2007, Epidemiologic reviews.

[71]  M. Kurt,et al.  Re: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.

[72]  K. Wallner,et al.  Influence of body mass index on biochemical outcome after permanent prostate brachytherapy. , 2005, Urology.

[73]  David Carling,et al.  The AMP-activated protein kinase cascade--a unifying system for energy control. , 2004, Trends in biochemical sciences.

[74]  B. Hoffman,et al.  Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[75]  Treatment of Obesity in Adults.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. , 1998, Obesity research.

[76]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.